GlycoMimetics Reports Third Quarter 2016 Results and Progress in Clinical Development

Go back to GlycoMimetics Reports Third Quarter 2016 Results and Progress in Clinical Development
GLYCOMIMETICS (NASDAQ: GLYC) Delayed: 0.16 --0 (-0%)
Previous Close $0.16    52 Week High $9.25 
Open $0.16    52 Week Low $3.70 
Day High $0.16    P/E N/A 
Day Low $0.16    EPS $0.00 
Volume 2,330